Search results
Found 30427 matches for
A multi-million pound, phase 3 clinical trial (EMPA-VISION) investigating a novel drug that could help failing hearts begins at the Oxford Centre for Clinical Magnetic Resonance Research (OCMR)
Stefan Piechnik
CVM OCMR Principal Investigators
DSc, PhD, MScEE, FSCMR Stefan Piechnik - Professor of Biomedical Imaging
Parag Gajendragadkar
CVM Researchers
MA, MB BChir, MPhil (Cantab), DPhil (Oxon), MRCP Parag Gajendragadkar - Senior Clinical Fellow in Electrophysiology
Naveed Akbar
CVM Principal Investigators
BSc (Hons), MSc, PhD, FHEA Naveed Akbar - ASSOCIATE PROFESSOR OF CARDIOVASCULAR SCIENCE
Elizabeth Ormondroyd
CVM Principal Investigators
PhD; MSc Genetic Counselling Elizabeth Ormondroyd - Principal Investigator in RDM; Senior researcher; Genetic counsellor
Reshma Ramracheya
OCDEM Visitors and Affiliates
BSc (Hons), PhD Reshma Ramracheya - Visiting Scientist
Timothy Betts
CVM Principal Investigators
MD, MBChB, FRCP Timothy Betts - Associate Professor of Cardiovascular Medicine
Betty Raman
CVM OCMR Principal Investigators
MBBS DPhil FESC FRACP Betty Raman - Associate Professor of Cardiovascular Medicine
Suzanne Watt
Emeritus Professors NDCLS
B.Sc., B.Sc. (Hons), Ph.D., FRCPath. Suzanne Watt - Emeritus Professor of Haematology
Paul Johnson
OCDEM Principal Investigators
MA MD FRCS (Paed.Surg) FAAP Paul Johnson - Director of Oxford Islet Isolation and Islet Transplant Programmes and Professor of Paediatric Surgery
Peter Rothwell
AMIIC
MD PhD FRCP Peter Rothwell - Founding Director of the Wolfson Centre for the Prevention of Stroke and Dementia and Action Research Professor of Neurology